StockData
Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc. (LUCD) stock

LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3034% above fair value
$0.40+0.00 (+0.30%)

Close on Nov 17, 2026Market cap $81.09MP/E –Yield –

Lucid Diagnostics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Lucid Diagnostics's price to book ratio was 6.7× on Nov 11, 2026, against 5.4× a year earlier. Over the last 4 years it ranged from 1.3× to 44.1×, with a median of 4.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.7×+1.1
2025Dec 31, 20255.5×−1.1
2024Dec 31, 20246.7×−16.7
2023Dec 29, 202323.4×+21.5
2022Dec 30, 20221.8×–

More Lucid Diagnostics figures

See a number that looks wrong?